— from Streamed.News —
Dr. Rox Anderson announced breakthroughs in pain control and genetic disease treatment. A novel injectable ice formulation, originating from research into lipid sensitivity to cold, offers a three-month nerve block for chronic pain relief. Concurrently, a clinical trial showed that deoxyolate, an FD
KI-gestützte Diagnosetests, selbst solche mit hohen Kosteneinsparungen, stehen vor erheblichen Verzögerungen bei Zulassung und Erstattung. David Spetzler (Diagnoseunternehmen) berichtete von einem Brustkrebs-Früherkennungstest, der Kosten halbieren könnte, aber zwei Jahre im Regulierungsprozess fest
AI-powered diagnostic tests, even those offering significant cost reductions, face substantial delays in gaining regulatory approval and reimbursement. David Spetzler of a diagnostic company highlighted a breast cancer early recurrence test that could halve costs compared to existing options, yet is